Search - tctmd.com

Displaying 221 - 240 of 59286

Sort: Relevancy | Date

Presentation THT 2026

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Presenter: David A. Baran

March 03, 2026

Presentation THT 2026

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Presenter: Thitiphan Srikulmontri

March 03, 2026

Presentation THT 2026

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Presenter: Nir Uriel

March 03, 2026

Presentation THT 2026

Designing Studies for Gene Therapy for Rare Diseases

Presenter: Barry Greenberg

March 03, 2026

Presentation THT 2026

Keeping Patients out of DanGer

Presenter: Jacob Eifer Moeller

March 03, 2026

Presentation THT 2026

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Presenter: Karl-Philipp Rommel

March 03, 2026

Presentation THT 2026

Barostimulation Therapy for HFrEF

Presenter: Philip Adamson, MD

March 03, 2026

Presentation THT 2026

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Presenter: Sanjiv J. Shah

March 03, 2026

Presentation THT 2026

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Presenter: Roger J. Hajjar

March 03, 2026

Presentation THT 2026

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

Presenter: Marat Fudim

March 03, 2026

Presentation THT 2026

The Lymphatic System as a Target for ADHF

Presenter: Jan Biegus

March 03, 2026

Presentation THT 2026

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Presenter: Shamus Husheer

March 03, 2026

Presentation THT 2026

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Presenter: Arvind Bhimaraj

March 03, 2026

Presentation THT 2026

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Presenter: Grant Reed

March 03, 2026

Presentation THT 2026

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Presenter: Michele Esposito

March 03, 2026

Presentation THT 2026

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Presenter: Toluwalase Awoyemi

March 03, 2026

Presentation THT 2026

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Presenter: Robby Wu

March 03, 2026

Presentation THT 2026

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Presenter: Nelson Wang

March 03, 2026

Advertisement

Wearable Cardiac Defibrillator for Newly Diagnosed HFrEF: Real World Evidence

Real-World Outcomes of Eplerenone in Non-Obstructive Hypertrophic Cardiomyopathy

SCAI Stages of Cardiogenic Shock: Past, Present and Future

Impact of Baseline Tricuspid Regurgitation on Outcomes in Heart Failure Patients Undergoing Mitral TEER

Cardiac Contractility Modulation: Combining CCM and ICD Therapy

Designing Studies for Gene Therapy for Rare Diseases

Keeping Patients out of DanGer

Central Venous Congestion in Transcatheter Tricuspid Repair: Lessons from the TRI.Fr Trial

Barostimulation Therapy for HFrEF

Atrial Shunt for Heart Failure with Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes from the REDUCE LAP-HF II Trial

Defining the Targets for Gene Therapy and Optimizing Vectors for Delivery

Medication Regimen Changes and Clinical Outcomes in the Cardiac Microcurrent (C-MIC) II Randomized Trial

The Lymphatic System as a Target for ADHF

Artificial Intelligence Meets Real-World Heart Failure: Early Results from the HF-TRACK Trial

Reducing Renal Venous Pressure to Improve Urine Output: Overview of Devices, Current Status, and Future Directions

Incidence of HF Therapy Escalation and Time-to-Clinical Worsening in Atrial Shunt- vs. Sham-Treated Patients with HFpEF/HFmrEF During 5-Year Follow-Up: REDUCE LAP-HF II Trial

Advanced Hemodynamics To Guide Recovery, Prognosis, and Clinical Care

Sex- and Race‑Based Differences in Outcomes Following Left Ventricular Assist Device Explant: A VAD Wean Registry Analysis

Pumps that Increase Renal Arterial Perfusion Pressure: Current Status and Future Directions

Optimal Mean Arterial Pressure, Time in Target Range, and Outcomes in HeartMate 3 Recipients: Pooled Individual-Patient Data from MOMENTUM-3 and ARIES-HM3 Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content